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aims: The embryonic-like stem cell origin of infantile hemangioma (IH) and the observed 
elevated serum levels of alpha-fetoprotein (AFP) in patients with hepatic IH led us to 
investigate if this tumor was the source of AFP.
Materials and methods: We measured serial serum levels of AFP in patients with 
problematic proliferating IH treated with surgical excision or propranolol treatment. We 
also investigated the expression of AFP in extrahepatic IH samples using immunohisto-
chemical staining, mass spectrometry, NanoString gene expression analysis, and in situ 
hybridization.
results: Serum levels of AFP normalized following surgical excision or propranolol treat-
ment. Multiple regression analysis for curve fittings revealed a different curve compared 
to reported normal values in the general populations. AFP was not detected in any of the 
IH samples examined at either the transcriptional or translational levels.
conclusion: This study demonstrates the association of proliferating IH with elevated 
serum levels of AFP, which normalized following surgical excision or propranolol treat-
ment. We have shown that IH is not the direct source of AFP. An interaction between 
the primitive mesoderm-derived IH and the endogenous endodermal tissues, such as 
the liver, via an intermediary, may explain the elevated serum levels of AFP in infants with 
extrahepatic IH.
Keywords: alpha-fetoprotein, infantile hemangioma, endoderm, primitive mesoderm, extrahepatic
inTrODUcTiOn
Infantile hemangioma (IH) typically undergoes rapid proliferation during infancy (proliferative 
phase) followed by spontaneous slow involution over the next 1–5 years (involuting phase) with 
continued improvement up to 10 years, often leaving a fibro-fatty residuum (involuted phase) (1, 2). 
Recent studies have demonstrated an abundance of stem cells expressing embryonic stem cell (ESC) 
markers in IH during the proliferative phase (3–5). IH-derived stem cells possess the capability 
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to produce mesoderm and ectoderm downstream derivatives, 
including adipocytes, osteoblasts, erythrocytes, and neuronal 
cells, confirming their primitive nature (4, 6–8).
Of interest, these stem cells in IH that express ESC markers 
do not form teratomas in vivo (3, 4) that are typically observed in 
ESC-derived tumors (9). This infers that the stem cell population 
within IH is downstream of ESC, with published data showing 
this primitive population being localized to the endothelium of 
the microvessels (3, 5, 10).
Recent investigations into the biology of IH suggest a placental 
chorionic villous mesenchymal core cell (PCVMCC) origin of 
IH (11). This is supported by the expression profile of IH show-
ing the primitive mesoderm origin of these primitive cells (10) 
and the unique co-expression of proteins common to both IH 
and placenta (11, 12). This would imply that the cells from the 
primitive streak in the fetus proper that eventually give rise to 
the PCVMCC also give rise to cells of the yolk sac (13). These 
primitive cells are presumed to embolize into the fetus proper 
in utero via the umbilical vein, through the portal vein, with the 
liver being the first fetal transition organ prior to their ultimate 
entry into the fetal arterial circulation (11). This may account 
for the increased risk of hepatic involvement in patients with 
multiple cutaneous IH lesions (14).
Alpha-fetoprotein (AFP), a protein similar to albumin, is 
normally produced by the liver, yolk sac, and the gastrointestinal 
tract (15). It is an important biomarker for certain tumors and liver 
diseases in childhood (16). Interestingly AFP is also associated with 
the onset of endodermal differentiation from ESC (17). Elevated 
serum levels of AFP have also been reported in patients with hepatic 
IH (18) and infantile hepatic hemangioendothelioma (19, 20).
Previous reports documenting increased levels of circulating 
AFP in patients with hepatic IH led to the hypothesis that IH may 
be the source of circulating AFP, rather than being the effector 
as previously proposed (19). However, what remain to be deter-
mined are the serum levels of AFP in infants with extrahepatic 
IH, compared to the physiologically elevated levels postnatally.
This study analyzed serial serum levels of AFP in patients 
undergoing surgical excision or propranolol treatment for prob-
lematic extrahepatic IH. We also investigated the expression of 
AFP in IH tissues at the transcriptional and translational levels to 
determine if IH was the source of AFP production.
MaTerials anD MeThODs
analysis of serum levels of aFP
Patients with problematic proliferating IH aged 2–12 (mean, 5.8) 
months were prospectively recruited from our Vascular Anomalies 
Center, in a study approved by the Central Health and Disability 
Ethics Committee. The demographic data of the patients and 
the characteristics of their IH are presented in Table 1. Patients 
treated conservatively were excluded from the study.
All patients underwent blood collection by venipuncture 
before the initiation of propranolol treatment. For patients 
undergoing surgical excision, blood samples were obtained 
immediately following induction of anesthesia. Blood samples 
were collected 3, 6, and 9 months following surgical excision or 
initiation of propranolol treatment. Blood samples were analyzed 
for AFP at the Capital and Coast Laboratory (Wellington, NZ) 
using Roche Cobas e601 by Electrochemiluminescence (refer-
ence range, 0–10 kU/L) and were converted into nanograms per 
milliliter for each measurement, to be consistent with the value 
in published reports (21, 22). Participants with elevated levels of 
AFP, based on normal values reported in the literature (21, 22) 
underwent liver ultrasonography to exclude hepatic pathology.
Tissue samples
Surgically excised proliferating (n  =  6, including three from 
the cohort of patients in this study) and involuted (n =  6) IH 
tissues obtained from patients aged 3–10 (mean, 6) months and 
6–12 (mean 9) years, respectively, were used for immunohisto-
chemical (IHC) and mRNA in situ hybridization (ISH) staining, 
NanoString, and mass spectrometry analyses.
immunohistochemical staining
4-μm-thick formalin-fixed paraffin-embedded IH sections under-
went 3,3-diaminobenzidine (DAB) immunohistochemical IHC 
staining with the primary antibodies for AFP (ready-to-use, Leica, 
Sydney, Australia) and smooth muscle actin (SMA, ready-to-use, 
Leica) on the Bond Rx Autostainer (Leica) using an established 
protocol (23–25). All slides were counterstained with hematoxylin 
(Leica) and mounted with Surgipath Micromount Media (Leica). 
Infant liver sections were used as a positive control for AFP.
In Situ hybridization
Proliferating (n = 3) and involuting (n = 3) IH samples from the 
same cohorts used for IHC staining were subjected to ISH using 
the AFP probe (NM_001134, Affymetrix, CA, USA) on the Bond 
Rx Autostainer (Leica) using a recently described protocol (23). 
Infant liver sections were used as a positive control. All slides were 
counterstained with hematoxylin (Leica).
nanostring gene expression analysis
The RNeasy Mini Kit (Qiagen) was used on snap-frozen pro-
liferating (n =  6) and involuted (n =  6) IH samples to extract 
RNA. The RNA samples were validated using the NanoDrop2000 
Spectrophotometer (Thermo Scientific). The samples were then 
analyzed with the NanoString nCounter™ Gene Expression 
Assay (NanoString Technologies, Seattle, WA, USA), which 
was conducted by New Zealand Genomics Ltd. (Dunedin, NZ, 
USA) according to the manufacturer’s protocol. NanoString 
Technologies designed and synthesized the probes for the genes 
encoding AFP (NM_000789.2) and the house keeping gene 
GAPDH (NM_002046.3). The standard settings of nSolver soft-
ware (NanoString Technologies) were used to normalize and vali-
date the data against in house controls. The data were expressed as 
a ratio over the housekeeping gene for normalization.
Mass spectrometry
Total protein extraction, digestion, and mass spectrometry were 
performed as described previously (24). Briefly, snap-frozen 
proliferating (n = 2) and involuted (n = 2) IH tissues from the 
same cohorts used for IHC staining were homogenized with 
a Dounce Homogenizer (Thomas Co., Philadelphia, PA, USA) 
TaBle 1 | Demographic details of the patients and characteristics of their problematic proliferating infantile hemangioma.
Patient Treatment age (months) size of main lesion (cm) site of main lesion number of lesions sex gestation (weeks)
1 Propranolol 5 10 × 8 Chest 1 F 36
2 Propranolol 11 4 × 3.5 Shoulder 1 F 41
3 Propranolol 3 10 × 8 Cheek/parotid 1 F 40
4 Propranolol 3 0.8 × 0.8 Upper lip 1 F 34
5 Propranolol 7 1 × 1 Lower eyelid 1 F 38
6 Propranolol 3 1.5 × 1.5 Nose 4 M 32
7 Propranolol 3 12 × 4 Elbow 1 F 40
8 Propranolol 3 2 × 3 Ear 1 F 36
9 Propranolol 2 2.5 × 5 Nose 1 M 39
10 Propranolol 3 8 × 5 Arm 1 F 39
11 Propranolol 5 2 × 1.5 Upper eyelid 1 F 40
12 Propranolol 4 8 × 8 Buttock 1 M 40
13 Surgery 7 2 × 2 Neck 1 M 33
14 Surgery 6 4 × 3 Buttock/back 2 M 35
15 Surgery 7 2.5 × 3.5 Labia majora 1 F 40
16 Surgery 8 2 × 2 Mons pubis 1 F 39
17 Surgery 12 3 × 3 Scalp 1 F 38
18 Surgery 4 2.5 × 2 Natal cleft 1 M 40
19 Surgery 9 2 × 2 Scalp 1 F 38
20 Surgery 5 3.5 × 3 Labia 1 F 40
21 Surgery 12 1.5 × 1.5 Eyebrow 2 F 40
22 Surgery 7 2.5 × 1.5 Temple 2 F 37
23 Surgery 6 2.5 × 2.5 Neck 2 F 41
24 Surgery 4 3 × 1.5 Scalp 1 M 40
M, male; F, female.
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in ice-cold RIPA buffer (Sigma-Aldrich, St. Louis, MA, USA) 
containing Complete Protease inhibitor (Roche Life Science, 
Penzberg, Germany), and after quantitation (Qubit® 2.0 
Fluorometer, Life Technologies, San Diego, CA, USA), 100 mg 
of total protein per sample was precipitated overnight at −20°C 
(ProteoExtract® Protein Precipitation Kit, Merck Millipore, 
Billerica, MA, USA). Protein pellets were resuspended in 
100  mM TEAB buffer (pH 8.5) (Sigma-Aldrich) containing 
5% sodium deoxycholate (SDC, Merck, Darmstadt, Germany) 
and 10  mM dithiothreitol (Sigma-Aldrich) and incubated 
at 80°C for 30  min. After alkylation (40  mM iodoacteamide, 
Sigma-Aldrich) and dilution (10-fold in 100 mM TEAB buffer, 
pH 8.5), digestion was performed overnight at 37°C using 4 mg 
trypsin (Roche Life Science, Penzberg, Germany) per sample. 
SDC was removed by formic acid (Merck) precipitation (1% 
final). After lyophilization to ~10 μL, each sample was recon-
stituted in 0.1% formic acid, purified (OMIX C18 pipette tip, 
Agilent Technologies, Santa Clara, CA, USA), and prepared for 
LC–MS/MS.
LC–MS/MS was performed using an UltiMate 3000 HPLC 
system (Dionex, Thermo Scientific, Waltham, MA, USA) 
and LTQ Orbitrap XL mass spectrometer (Thermo Scientific, 
Waltham, MA, USA) and each sample was analyzed in quadru-
plicate. Eluted peptides were analyzed using data-dependent MS/
MS acquisition, and raw MS/MS data files were searched against 
a complete human protein database (SwissProt KB, October 
22, 2014, 69689 sequences) using Proteome Discoverer™ 
V1.4 (Thermo Scientific, Waltham, MA, USA) and Scaffold 4.0 
(Proteome Software, Portland, OR, USA). Peptide assignments 
were accepted above 90% confidence, and protein identification 
parameters were: protein threshold, 1.0% FDR; minimum total 
spectrum count, 2; and peptide threshold, 1.0% FDR.
statistical analysis of serum levels of 
aFP
To determine the significance of surgical excision or propranolol 
treatment on serial AFP levels for our IH patients, we performed 
t tests, using SPSS (V.22) for paired samples before and 1 month 
after surgical excision or propranolol treatment.
Serum levels of AFP recorded by the age (in months) of IH 
patients were compared with the norms for postnatal levels of 
AFP in the general American (21) and Japanese (22) populations. 
Conversion from our original kilounits per liter AFP units to the 
nanograms per milliliter units of the US (21) and Japanese (22) 
norms, as expected, left the correlation values unchanged but with 
the F value still massive but halved by rounding effects. As there 
is no convenient significance test of the difference in distributions 
of IH individual’s levels and distributions of mean levels over time, 
a curve fitting exercise was done to investigate the difference 
between serial serum levels of AFP in IH patients in this study 
and the normal levels. SPSS (V.22) curve fit was used for 11 differ-
ent types of distributions: linear, growth, quadratic, compound, 
logarithmic, cubic, S, exponential, inverse, power, and logistic.
resUlTs
analysis of serum levels of aFP
Of the 24 patients recruited into this study, 12 underwent surgical 
excision and 12 had propranolol treatment. Table  1 shows the 
FigUre 1 | curve function for serum levels of aFP for infantile hemangioma (a), normal american (21) (B), and Japanese (22) (c) children, with the 
analysis values for each of the groups.
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demographics of the patients and the characteristics of their IH 
lesions. Liver ultrasonography of the patients with elevated serum 
AFP revealed no hepatic lesions.
Analysis of serial serum levels of AFP for both the surgical 
excision and the propranolol treatment cohorts demonstrated 
tapering serum levels of AFP in both groups, concordant with 
the patients’ age. The t tests comparing pretreatment AFP 
levels and 1 month posttreatment levels revealed a significant 
reduction of AFP levels for patients who were on propranolol 
(p = 0.014), but not those who had undergone surgical excision 
(p = 0.189).
Analysis of the serial AFP levels based on the results of previ-
ously reported normal serum levels of AFP in the American 
(Figure  1B) (21) and Japanese (Figure  1C) (22) populations 
are effectively the same with R2’s of 0.978 and 0.979 respectively, 
and F values of 371.5 and 271.6 (Table  2), respectively. This 
leaves the power function with the better fit for the norms 
than the exponential function with respective R2‘s of 0.910 and 
0.901 and associated F values of 271.6 and 80.6. It is in contrast 
to the group of IH patients in our study, which gave a power 
function fit of R2 = 0.948 with an F of 145.6, but an exponential 
function fit of R2 = 0.999 (Table 2) with an F of 15028.5, giving 
a perfect fit for the exponential function (Figure  1A). Thus 
Figures  1A–C illustrate the plots of the individual datasets 
with the functional analysis, demonstrating that the pattern of 
serial serum levels of AFP in children with IH are substantially 
different from those of the norms for normal American (21) and 
Japanese (22) children.
immunohistochemical staining
All IH samples used in this study showed expression of GLUT-1 
by the endothelium of the microvessels (data not shown), con-
firming the diagnosis. To investigate if the increased levels of 
circulating AFP in patients with proliferating IH were derived 
from within the IH, we performed IHC staining for AFP in 
proliferating (Figure  2A, brown) and involuted (Figure  2B, 
brown) IH lesions. All IH lesions were counterstained with 
SMA (Figures  2A,B, red) to demonstrate the pericyte layer 
of the microvessels. There was no expression of AFP in all the 
lesions examined. The normal infant liver sections used as a 
positive control demonstrated positive staining (Image S1A in 
Supplementary Material, brown).
In Situ hybridization
To confirm the absence of AFP in IH with IHC staining we inves-
tigated for the presence of AFP at the transcriptional level. All IH 
samples used for ISH did not show positive staining for AFP in 
both proliferating (Figure 2C, red) and involuted (Figure 2D, red) 
samples. Specificity of the AFP probe was confirmed with infant 
liver sections as a positive control (Image S1B in Supplementary 
Material, red).
TaBle 2 | Functional analysis of serial serum levels of aFP in children with infantile hemangioma and normal american (21) and Japanese (22) children.
ih american Japanese
Function R2 F R2 F R2 F
Power 0.948 145.5 0.979 371.5 0.978 271.6
Exponential 0.999 7442 0.910 54.6 0.901 80.6
IH, infantile hemangioma.
FigUre 2 | representative 3,3-diaminobenzidine immunohistochemical (a,B) and in situ hybridization (c,D) stained sections of proliferating (a,c) 
and involuted (B,D) infantile hemangiomas (ih) demonstrating the absence of aFP [(a,B), brown; (c,D), red]. The IHC-stained IH sections were also 
stained with SMA [(a,B), red], identifying the pericyte layer of the microvessels. All slides were counterstained with hematoxylin to identify cell nuclei [(a–D), blue]. 
Image magnification: 400×.
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nanostring gene expression analysis
To validate the results of ISH staining, copy number of AFP 
mRNA was analyzed in the same proliferating (n = 6) and invo-
luted (n = 6) IH lesions from the cohorts used for IHC staining. 
The mRNA expression for AFP was not detectable above the 
levels of the negative controls (data not shown).
Mass spectrometry
Total protein extracts from proliferating (n = 2) and involuted 
(n = 2) IH tissue samples from the same cohorts used for IHC 
staining were trypsin digested and analyzed by liquid chromatog-
raphy–orbitrap mass spectrometry. Searching against a complete 
human protein database resulted in the identification of 773 
proteins with a minimum of two matched tryptic peptides (1.2% 
FDR), of which 682 were common to both phases of IH. Despite 
allowing for up to two missed tryptic cleavage sites, which gener-
ated 157 theoretical tryptic peptides from the full-length protein, 
AFP was not detected in any of the IH samples analyzed (data 
not shown).
DiscUssiOn
Recent advances in the understanding of IH have revealed a novel 
stem cell niche (1, 4, 5, 10, 26) with a putative PCVMCC origin 
(11). These placenta-derived cells share a common origin with 
the primitive mesoderm cells of the yolk sac, which is the source 
of AFP in utero (27). Normalization of serum levels of AFP fol-
lowing surgical excision or propranolol treatment supports the 
association of circulating AFP and IH, as described in this report. 
The contrasting exponential decay patterns of serial serum levels 
of AFP in IH infants following surgical excision or propranolol 
treatment reported in this study, compared with the normal 
populations (21, 22), further supports an association between 
IH and increased serum levels of AFP. However, what remains 
unknown is whether IH is directly or indirectly responsible for 
the increased AFP production.
Elevated serum levels of AFP have been reported in patients 
with hepatic IH (18). Elevated serum levels of AFP have also been 
reported in infants with hepatic hemangioendothelioma (19, 20), 
with AFP being expressed on the surrounding hepatocytes (28).
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A previous publication reports the absence of AFP in IH, based 
solely on IHC staining (29). To the best of our knowledge, this is 
the first report showing the absence of the expression of AFP in 
extrahepatic proliferating IH lesions at both the transcriptional 
and translational levels.
Physiologically serum levels of AFP are very high at birth, and 
taper exponentially postnatally to near normal adult levels (20 ng/
mL) by 8–9 months of age (15, 30). However, given the associa-
tion of AFP production with hepatic tumors, such as hepatocel-
lular carcinoma and hepatoblastoma (31), we have performed 
liver ultrasonography in infants with high levels of AFP in this 
study to exclude the presence of these tumors. Interestingly, none 
of the IH patients with high serum levels of AFP in this study 
showed hepatic pathology. This suggests an association between 
IH and raised serum levels of AFP, which is independent of liver 
involvement by IH.
Recent demonstration of the expression of ESC markers 
in proliferating IH, coupled with the speculated capability of 
IH-derived cells to undergo in  vitro differentiation down an 
endodermal lineage that expresses AFP, led us to hypothesize that 
IH may be the direct source of AFP production. Intriguingly, we 
were not able to detect the expression of AFP in any of the IH 
samples examined in this study, at either the transcriptional or 
translational level. We speculate that the elevated serum levels of 
AFP are indirectly caused by IH, possibly through one or more 
intermediaries between the IH and downstream AFP production.
The endodermal element of the yolk sac that produces AFP 
in utero (27) is situated immediately adjacent to the outer extra-
embryonic mesoderm, which is derived from the primitive 
mesoderm (13), the putative origin of IH (10, 11). It is exciting 
to speculate that an interaction between the primitive mesoderm 
derived IH, and the endogenous endodermal tissues, such as liver, 
results in AFP production by the latter. This suggests possible 
secretion of a messenger protein by proliferating IH that causes a 
tissue of endodermal origin to produce AFP. However, this is the 
topic of further investigation.
This study is the first to demonstrate elevated serum levels 
of AFP in patients with non-hepatic proliferating IH and the 
absence of AFP in IH tissue samples. An interaction between 
the primitive mesoderm derived IH, and the endogenous 
endodermal tissues, such as liver, via an intermediary, may 
explain the elevated serum levels of AFP in infants with extra-
hepatic IH.
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